Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

This program funds research that advances the understanding, development, and clinical investigation of experimental antiviral drugs for emerging or re-emerging viral infections. It supports work creating candidate antiviral therapies and prophylactics targeting conserved viral or host mechanisms to improve preparedness for future epidemics or pandemics.

Amount: €9M — €11M
Type: Program

Key facts

Key facts for Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Amount	€9M — €11M — €44.2M shared across the programme
Issuer	Horizon Europe
Who can apply	See eligibility details
Sectors	Climate · HealthTech
Deadline	Closes 17 Feb 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: ec.europa.eu ↗

Source checked 12 hours ago

10 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Selection of hosting sites and fellows for EFSA's European Food Risk Assessment Fellowship (EU-FORA) Programme		Closes 24 Feb 2027
Call for proposals for operating grants in 2027 to non-governmental organisations: financial contribution to the functioning of health non-governmental organisations implementing one or more specific objectives of Regulation (EU) 2021/522 (OA-g-26-91 )		Closes 19 Jan 2027